These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26283744)

  • 21. Treatment of cutaneous leishmaniasis among travellers.
    Blum J; Desjeux P; Schwartz E; Beck B; Hatz C
    J Antimicrob Chemother; 2004 Feb; 53(2):158-66. PubMed ID: 14729756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Penile sporotrichoid cutaneous leishmaniasis].
    Masmoudi A; Boudaya S; Bouzid L; Frigui F; Meziou TJ; Akrout F; Turki H; Zahaf A
    Bull Soc Pathol Exot; 2005 Dec; 98(5):380-1. PubMed ID: 16425718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular analysis of cutaneous leishmaniasis lymphadenopathy: insights into the early phases of human disease.
    Bomfim G; Andrade BB; Santos S; Clarêncio J; Barral-Netto M; Barral A
    Am J Trop Med Hyg; 2007 Nov; 77(5):854-9. PubMed ID: 17984342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current treatment for cutaneous leishmaniasis: a review.
    Palumbo E
    Am J Ther; 2009; 16(2):178-82. PubMed ID: 19300044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
    Layegh P; Yazdanpanah MJ; Vosugh EM; Pezeshkpoor F; Shakeri MT; Moghiman T
    Am J Trop Med Hyg; 2007 Jul; 77(1):99-101. PubMed ID: 17620637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous lupoid leishmaniasis: a case report.
    Ferahbaş A; Mistik S; Utaş S; Yaman O; Canoz O; Doganay M; Aşçioglu O
    Cutis; 2006 Jan; 77(1):25-8; quiz 37-8. PubMed ID: 16475491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey.
    Uzun S; Durdu M; Culha G; Allahverdiyev AM; Memisoglu HR
    J Parasitol; 2004 Aug; 90(4):853-9. PubMed ID: 15357081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rash with regional lymphadenopathy.
    Bradley VR; Liu V; Haynes HA
    Arch Dermatol; 2003 Aug; 139(8):1075-80. PubMed ID: 12925398
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cutaneous leishmaniasis treated with ambisome (liposomal amphotericin B)].
    Ben-Shimol S; Sagi O; Schwartz E; Greenberg D
    Harefuah; 2012 Aug; 151(8):458-60, 498. PubMed ID: 23350289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infiltrated leishmaniasis recidivans cutis on the face: a rare clinical presentation.
    Masood S; Naveed S; Alvi RU
    Trop Doct; 2012 Apr; 42(2):120-1. PubMed ID: 22337728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani.
    Ranawaka RR; Weerakoon HS
    J Dermatolog Treat; 2010 Sep; 21(5):286-93. PubMed ID: 20438389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized, double-blind, controlled, comparative study on intralesional 10% and 15% hypertonic saline versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis.
    Ranawaka RR; Weerakoon HS; de Silva SH
    Int J Dermatol; 2015; 54(5):555-63. PubMed ID: 25600472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Disseminated cutaneous leishmaniasis secondary to lymphoedema: two cases].
    Meziou TJ; Chaabène H; Masmoudi A; Boudaya S; Cheikhrouhou H; Bouassida S; Turki H
    Ann Dermatol Venereol; 2008 Feb; 135(2):123-6. PubMed ID: 18342094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An atypical case of cutaneous leishmaniasis caused by Leishmania infantum in Portugal.
    Lopes L; Vasconcelos P; Borges-Costa J; Soares-Almeida L; Campino L; Filipe P
    Dermatol Online J; 2013 Nov; 19(11):20407. PubMed ID: 24314782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features and diagnosis of 42 travellers with cutaneous leishmaniasis.
    Scarisbrick JJ; Chiodini PL; Watson J; Moody A; Armstrong M; Lockwood D; Bryceson A; Vega-López F
    Travel Med Infect Dis; 2006 Jan; 4(1):14-21. PubMed ID: 16887720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis.
    Patrício FJ; Costa GC; Pereira PV; Aragão-Filho WC; Sousa SM; Frazão JB; Pereira WS; Maciel MC; Silva LA; Amaral FM; Rebêlo JM; Guerra RN; Ribeiro MN; Nascimento FR
    J Ethnopharmacol; 2008 Jan; 115(2):313-9. PubMed ID: 18035510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mucocutaneous leishmaniasis in a HIV infected patient. Case report].
    Montenegro-Idrogo JJ; Montañez-Valverde RA; Chian C; Benites-Villafane C
    Rev Chilena Infectol; 2014 Oct; 31(5):610-4. PubMed ID: 25491462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol.
    Momeni AZ; Aminjavaheri M
    Eur J Dermatol; 2003; 13(1):40-3. PubMed ID: 12609780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical glyceryl trinitrate: a possible treatment for cutaneous leishmaniasis.
    Zeina B; Banfield C; al-Assad S
    Clin Exp Dermatol; 1997 Sep; 22(5):244-5. PubMed ID: 9536549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate.
    Sadeghian G; Nilfroushzadeh MA; Iraji F
    Clin Exp Dermatol; 2007 Jul; 32(4):371-4. PubMed ID: 17376205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.